SINOPHARM TECH (08156) Announces Annual Results: Loss Attributable to Shareholders of HK$9.142 Million, a Significant Year-on-Year Increase of 954.44%

SINOPHARM TECH (08156) released its annual results for the year ended June 30, 2026, with revenue of HK$45.582 million, a year-on-year decrease of 25.58%. Loss attributable to owners of the company was HK$9.142 million, a significant year-on-year increase of 954.44%. Loss per share was 1.97 HK cents. The announcement stated that the Board believes the increase in loss attributable to equity holders was mainly due to the net impact of the following items, including: (i) a significant year-on-year decline in revenue from the Group's supply chain services business; and (ii) an increase in selling and distribution expenses during the reporting period.